FLT3 and acute myeloid leukemia: In a murine xenograft model, AMD3465 promoted FLT3-mutated AML cells mobilizing into the peripheral blood, eliminated the stroma-mediated support of the microenvironment, and thus enhanced chemo-sensitivity of leukemic cells to cytarabine and FLT3 inhibitor sorafenib [73].